TIA news stories

Researchers will use TIA facilities and expertise to advance their work to discover a targeted medicine that boosts the immune

Innovation in Australia’s health and medical research translation has been boosted with National Collaborative Research Infrastructure Strategy (NCRIS)- enabled health

Research in areas such as cancer, autoimmune disease, endometriosis, mental health, kidney disease and bacterial infection will advance with almost

Australian science continues to make national and international headlines, most recently focusing on the COVID-19 pandemic and the 2019 –

We are delighted to announce the outcomes of the first round of Pipeline Accelerator 2021-22 scheme. A total of $560,000

AIBN Professor Trent Munro is part of a new biotechnology company aiming to treat Type 2 diabetes using saliva from

AUCKLAND: COVID-19 Vaccination Corporation (CVC), New Zealand’s most experienced group of vaccine researchers have joined forces with Australia’s BASE Nucleic

TIA supports and facilitates researcher and SME access to a diverse range of Australian translational medical research infrastructure (see Table

The Biologics Innovation Facility (BIF) in collaboration with PerkinElmer have established a training facility to assist local biotech companies and

TIA is pleased to announce the outcomes of Pipeline Accelerator 2020-21 (Round 2). TIA is investing $620,000 in 18 ground-breaking

Every five years, the Australian Government consolidates and renews its policy approach to national research infrastructure (NRI) investment by engaging

TIA is pleased to announce our latest investment in a pilot facility at BASE, UQ to produce high-quality nucleic-acid (mRNA,

With the New Year comes new opportunities to learn new skills and explore new horizons. These opportunities for professional development

TIA held a information webinar on 2nd December 2020 to profile the expert services and advice available from the TIA

Global biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19

Researchers at the National Biologics Facility (NBF) at The University of Queensland will benefit from a substantial funding boost for

Developing early and improved diagnostic tests to lift ovarian cancer survival rates are the focus of two research projects commencing

A process developed by University of Queensland researchers to produce larger quantities of the Hendra virus therapeutic antibody could be